AZD1222
viral vector vaccine for prevention of COVID-19
Facts
15 properties- Instance of
- funded product
- Subclass of
- COVID-19 vaccine, adenovirus-based vaccine, vaccine candidate
- Announcement date
- November 2020[35]
- Clinical trial phase
- phase III clinical trial[34]
- Described by source
- A Study of a Candidate COVID-19 Vaccine (COV001), Investigating a Vaccine Against COVID-19, Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, A phase III study to investigate a vaccine against COVID-19, A phase I/II to determine efficacy, safety and immunogenicity of a candidate COVID-19 vaccine[25][26][27][28][29]
- Developer
- Jenner Institute, Oxford BioMedica, University of Oxford, Vaccines Manufacturing and Innovation Centre, Pall Corporation, Cobra Biologics (United Kingdom), AstraZeneca[14][15][16][17][18][19][20]
- Funder
- Coalition for Epidemic Preparedness Innovations, Biomedical Advanced Research and Development Authority, Government of the United Kingdom, GAVI, Operation Warp Speed[36][37][38][39][40]
- Manufacturer
- Oswaldo Cruz Foundation, Serum Institute of India, HALIX B.V., Advent SRL, Merck KGaA, Vaccitech, AstraZeneca, SK Bioscience, JCR Pharmaceuticals[5][6][7][8][9][10][11][12][13]
- Official name
- Vaxzevria[30]
- Route of administration
- intramuscular injection[21]
- Significant event
- phase I/II clinical trial (2020–present), phase III clinical trial (2020–present)[22][23]
- Sponsor
- AstraZeneca[24]
- Study type
- interventional study[41]
🏷️ Also known as
en Oxford–AstraZeneca COVID-19 vaccine
en Covishield
en Vaxzevria
en Oxford/AstraZeneca vaccine
en Oxford vaccine
en Astra vaccine
en AZD1222 Vaccine for the Prevention of COVID-19
en AZD 1222
en AZD-1222
en AZD1222
en AstraZeneca vaccine
en ChAdOx1 nCoV-19
en Consortium of the Jenner Institute COVID-19 vaccine candidate
ar لقاح آسترازينيكا
ar أي زد دي 1222
ar ChAdOx1 nCoV-19
ar لقاح أكسفورد
cs Covishield
cs britská vakcína
cs AZD1222
🔖 Identifiers · 13
- Image (Wikimedia Commons)
- Oxford AstraZeneca COVID-19 vaccine AZD1222 - 4.jpg ↗
- CAS Registry Number
- 2420395-83-9
- DrugBank ID
- DB15656
- Golden ID
- ChAdOx1_nCoV-19-5K8ZZ54
- Google Knowledge Graph ID
- /g/11mtfzp621
- MeSH descriptor ID
- D000090985
- MeSH tree code
- D20.215.894.865.450.250.500, D20.215.894.899.085.063
- PubChem Substance ID (SID)
- 434150987
- UNII
- B5S3K2V0G8
- VIOLIN ID
- 5774
- Vaccine Ontology ID
- VO_0005158
- WikiProjectMed ID
- Oxford–AstraZeneca COVID-19 vaccine
Show all 13 identifiers +1
- Yle topic ID
- 18-322199
🔗 Connections
← Uses 7
COVID-19 vaccination programme in India,
COVID-19 vaccination programme in the United Kingdom,
COVID-19 vaccination in Australia,
COVID-19 vaccination programme in Germany,
National Covid-19 Immunisation Programme (Malaysia),
COVID-19 vaccination in Thailand,
COVID-19 vaccination programme in Hong Kong
Funder 5
Manufacturer 5
Developer 4
Route of administration 1
Sponsor 1
Subclass of 1
Vaccine for 1
← Different from 1
← Has use 1
← Winner 1
Press Enter · cited answer in seconds